Evidence map›Paper›PMID 12796576›Full record

Trial reportAnnals of surgery2003

Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned.

Steven E Wolf, Steven J Thomas, Mohan R Dasu, Arny A Ferrando, David L Chinkes, Robert R Wolfe, David N Herndon

Registry-linked trialAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Annals of surgery, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03091075 (Ability of Oral Steroid), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03091075 naterminatednot on this mapstarted 2018, after this paper: background citation

Ability of Oral Steroid (Oxandrolone) to Halt Fatty Infiltration and Aid Rotator Cuff Healing: A Double-Blind, Randomized Clinical Trial

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2018 to 2026Enrolled4ConditionsRotator Cuff TearArmsOxandrolone, Placebo
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Early versus delayed enteral nutrition support for burn injuries.The Cochrane database of systematic reviews · 2006
    Pooled it
  2. Trial
  3. Early rehabilitative exercise training in the recovery from pediatric burn.Medicine and science in sports and exercise · 2014
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.Journal of burn care & research : official publication of the American Burn Association
    Trial
  8. Review
  9. Review
  10. Article
  11. A Reappraisal of Oxandrolone in Burn Management.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Burn-induced hypermetabolism and skeletal muscle dysfunction.American journal of physiology. Cell physiology · 2021
    Review
  16. Review
  17. Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.Burns : journal of the International Society for Burn Injuries · 2020
    Review
  18. Observational
  19. The Long-Term Impact of Severe Burn Trauma on Musculoskeletal Health.Journal of burn care & research : official publication of the American Burn Association · 2018
    Review
  20. New technologies in global burn care - a review of recent advances.International journal of burns and trauma · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Steven E WolfDepartment of Surgery, Shriners Burns Hospital, University of Texas Medical Branch, 815 Market, Galveston, TX 77550, USA. swolf@utmb.edu
Steven J Thomas
Mohan R Dasu
Arny A Ferrando
David L Chinkes
Robert R Wolfe
David N Herndon

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
Project 9: The role of androgen/corticosteroid in fat, muscle and glucose metabolism of burn victimsP50GM060338 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SZABO, CSABA · 2000 to 2017
$24.2M
MODULATION OF THE POSTBURN HYPERMETABOLIC RESPONSER01GM056687 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HERNDON, DAVID N. · 1998 to 2017
$9.0M
POSTDOCTORAL TRAINING IN TRAUMA &BURNST32GM008256 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Celeste Campbell Finnerty, Oscar E. Suman-Vejas · 1990 to 2026
$4.0M
NIA NIH HHS P30 AG024832NIGMS NIH HHS P50 GM060338NIGMS NIH HHS P50 GM 60338NIGMS NIH HHS R01 GM056687NIGMS NIH HHS R01 GM 56687NIGMS NIH HHS T32 GM008256NIGMS NIH HHS T32 GM 08256
6 · The paper itself

Abstract

objectiveTo determine the effects of the anabolic agent oxandrolone on muscle protein and gene expression in severely burned children. SUMMARY BACKGROUND DATA: The authors previously showed that oxandrolone increased net muscle protein synthesis in emaciated burned patients receiving delayed treatment for severe burns. They hypothesized that similar effects would be seen in those treated early after burn.

methodsThirty-two severely burned children were enrolled in a prospective randomized trial. Subjects underwent studies to assess leg protein net balance 5 days after the first excision and grafting procedure. Immediately after these studies, treatment with placebo (n = 18) or 0.1 mg/kg oxandrolone (n = 14) twice a day was started. One week after this, another net balance study was performed in each subject. Body weights and total body potassium counting were used to determine body compositional changes. Muscle biopsies were taken 1 week after treatment in oxandrolone subjects to examine gene expression changes with gene array (12,600 genes).

resultsProtein net balance did not change in the placebo group, while oxandrolone-treated subjects had a significant improvement. Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. Expression changes were seen in 14 genes in the oxandrolone group compared to placebo. Some of these included myosin light chain (+2.7-fold change), tubulin (+2.3), calmodulin (-2.3), and protein phosphatase I inhibitor (-2.8).

conclusionsOxandrolone improves protein net balance and lean mass in the severely burned. These changes are associated with increased gene expression for functional muscle proteins.

Indexed as

Amino AcidsAnabolic AgentsBody CompositionBurnsChildFood AdditivesFood, FormulatedGene ExpressionHumansMuscle ProteinsOligonucleotide Array Sequence AnalysisOrganic ChemicalsOxandroloneProtein Array AnalysisAmino AcidsAnabolic AgentsFood AdditivesMuscle ProteinsOrganic ChemicalsOxandroloneVivonex

Identifiers

PMID12796576
PMCPMC1514675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.